CrestarBio is dedicated to providing high quality biomaterials and human tissues for research purposes. Our goal is to partner with our clients and to assist in developing a deeper understanding of human disease processes and their underlying mechanisms. We provide high quality biospecimens and support services necessary for advancing genomics, proteomics, and biomarker research.
CrestarBio helps accelerate drug target discovery validation, leading to new and improved therapeutics. We facilitate scientific discovery from the lab into clinical practice.
We provide a wide range of specimen types, including matched sets of normal and diseased human tissues, FFPE blocks, whole blood, serum and plasma with associated and customized patient data focusing primarily on Oncology. Samples in other therapeutic areas such as cardiovascular disease, central nervous system disorders, and other disease such as diabetes and hypertension are also available.
CrestarBio provides tissue and tissue derivatives that are high quality, cost effective and procured in compliance with current and anticipated regulations throughout our global repository. Our company obtains its clinical specimens under strict IRB approved protocols with informed consent and uncompromising adherence to issues of patient safety, anonymity, and patient confidentiality. Informed consent is required from all donors irrespective of the host country regulatory requirements. Compliance with FDA regulations and adherence to international ethical standards such as ICH-GCP is paramount to our mission. Independent IRB and local ethics committee approvals are maintained at each clinical site.
All specimens are collected, processed and handled as per protocols that are approved by designated IRB and/or Ethics Committees.
Regulatory and Ethics Our Biospecimens and clinical data are handled in accordance with the highest ethical standards and in strictest compliance with all applicable rules and regulations including the recommendations of the Council of the Human Genome Organization (HUGO) Ethical, Legal, and Social Issues Committee (HUGO-ELSI, 1998); with the United Nations Educational, Scientific, and Cultural Organizationís (UNESCO) Universal Declaration on the Human Genome and Human Rights (1997); and with recommendations guiding physicians in biomedical research involving human subjects adopted by the 18th World Medical Assembly, Helsinki, Finland, 1964 and later revisions.
Our customized approach to providing these procurement services guarantees that every biospecimen is specifically tailored to each clientís needs. This custom service has made us an industry leader in the biotechnology, pharmaceutical, and related research fields. Our clients are assured of the highest quality products and customized service resulting from years of experience with global collection sites around the globe.